Praxis Precision Medicines, Inc.
US ˙ NasdaqGS ˙ US74006W2070

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Jeffrey Chodakewitz. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Jeffrey Chodakewitz har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:SDGR / Schrödinger, Inc. Director 17.247
US:ACET / Adicet Bio, Inc. Director 17.700
US:PRAX / Praxis Precision Medicines, Inc. Director 22.753
Director 16.500
US:VRTX / Vertex Pharmaceuticals Incorporated EVP GMDA, CMO 69.663
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Jeffrey Chodakewitz. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb PRAX / Praxis Precision Medicines, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PRAX / Praxis Precision Medicines, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PRAX / Praxis Precision Medicines, Inc. Insider Trades
Insidersalg PRAX / Praxis Precision Medicines, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PRAX / Praxis Precision Medicines, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PRAX / Praxis Precision Medicines, Inc. Insider Trades
Insiderkøb SDGR / Schrödinger, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PRAX / Praxis Precision Medicines, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SDGR / Schrödinger, Inc. Insider Trades
Insidersalg SDGR / Schrödinger, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PRAX / Praxis Precision Medicines, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SDGR / Schrödinger, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Jeffrey Chodakewitz som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-20 2025-06-18 4 SDGR Schrodinger, Inc.
Common Stock
A - Award 5.997 17.247 53,31
2025-06-13 2025-06-11 4 ACET Adicet Bio, Inc.
Common Stock
A - Award 5.900 17.700 50,00
2024-06-20 2024-06-18 4 SDGR Schrodinger, Inc.
Common Stock
A - Award 5.000 11.250 80,00
2024-06-07 2024-06-05 4 ACET Adicet Bio, Inc.
Common Stock
A - Award 5.900 11.800 100,00
2023-06-16 2023-06-15 4 SDGR Schrodinger, Inc.
Common Stock
A - Award 6.250 6.250
2023-06-02 2023-06-01 4 ACET Adicet Bio, Inc.
Common Stock
A - Award 5.900 5.900
2022-05-27 2022-05-26 4 PRAX Praxis Precision Medicines, Inc.
Stock Option (Right to Buy)
A - Award 22.753 22.753
2021-06-21 2021-06-17 4 SDGR Schrodinger, Inc.
Stock Option (right to buy)
A - Award 8.736 8.736
2021-05-04 2021-04-30 4 ACET Adicet Bio, Inc.
Stock Option (Right to Buy)
A - Award 18.500 18.500
2021-04-15 2021-04-13 4 PRAX Praxis Precision Medicines, Inc.
Stock Option (Right to Buy)
A - Award 38.579 38.579
2020-09-17 2020-09-17 4 ACET Adicet Bio, Inc.
Stock Option (Right to Buy)
A - Award 30.000 30.000
2020-06-05 2020-06-03 4 TORC resTORbio, Inc.
Stock Option (Right to Buy)
A - Award 14.414 14.414
2020-05-04 2020-04-30 4 SDGR Schrodinger, Inc.
Stock Option (right to buy)
A - Award 25.216 25.216
2019-06-11 2019-06-10 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 16.500 16.500
2019-05-09 2019-05-08 4 TORC resTORbio, Inc.
Stock Option (Right to Buy)
A - Award 14.414 14.414
2018-08-15 2018-08-14 4 TORC resTORbio, Inc.
Stock Option (Right to Buy)
A - Award 28.828 28.828
2018-06-01 2018-05-30 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 12.500 12.500
2018-02-14 2018-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 69.663 -0,43 153,69 -46.107 10.706.506
2018-02-14 2018-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 69.963 -0,57 152,62 -61.048 10.677.753
2018-02-14 2018-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.022 70.363 -2,79 151,26 -305.848 10.643.107
2018-02-14 2018-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.100 72.385 -1,50 150,47 -165.517 10.891.771
2018-02-14 2018-02-12 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.300 73.485 -1,74 149,21 -193.973 10.964.697
2018-02-08 2018-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 23.479 23.479
2018-02-08 2018-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 10.125 74.785 15,66
2018-02-08 2018-02-06 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.136 64.660 23,11
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -3.594 14.375 -20,00
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 52.524 -0,19 164,71 -16.471 8.651.228
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -900 52.624 -1,68 164,12 -147.708 8.636.651
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 53.524 -0,74 162,94 -65.176 8.721.201
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 53.924 -0,92 161,51 -80.755 8.709.265
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 54.424 -0,91 160,50 -80.250 8.735.052
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -700 54.924 -1,26 159,62 -111.734 8.766.969
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -494 55.624 -0,88 158,32 -78.210 8.806.392
2018-02-07 2018-02-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.594 56.118 6,84 109,14 392.249 6.124.719
2018-02-05 2018-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.796 14.368 -11,11
2018-02-05 2018-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 52.524 -0,19 169,49 -16.949 8.902.293
2018-02-05 2018-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 52.624 -0,19 168,06 -16.806 8.843.989
2018-02-05 2018-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -996 52.724 -1,85 166,10 -165.436 8.757.456
2018-02-05 2018-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 53.720 -1,10 165,23 -99.138 8.876.156
2018-02-05 2018-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.796 54.320 3,42 91,05 163.526 4.945.836
2018-02-05 2018-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.900 52.524 -3,49 167,44 -318.136 8.794.619
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.719 3.438 -33,33
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 54.424 -0,55 159,04 -47.712 8.655.593
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -900 54.724 -1,62 157,54 -141.786 8.621.219
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -519 55.624 -0,92 155,80 -80.860 8.666.219
2018-01-17 2018-01-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.719 56.143 3,16 96,87 166.520 5.438.572
2018-01-03 2018-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -3.438 0 -100,00
2018-01-03 2018-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -863 54.424 -1,56 152,80 -131.866 8.315.987
2018-01-03 2018-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.600 55.287 -2,81 152,06 -243.296 8.406.941
2018-01-03 2018-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -675 56.887 -1,17 150,87 -101.837 8.582.542
2018-01-03 2018-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 57.562 -0,52 149,65 -44.895 8.614.153
2018-01-03 2018-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.438 57.862 6,32 73,51 252.727 4.253.436
2017-11-06 2017-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -3.594 17.969 -16,67
2017-11-06 2017-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.594 54.424 -6,19 144,69 -520.016 7.874.609
2017-11-06 2017-11-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.594 58.018 6,60 109,14 392.249 6.332.085
2017-11-06 2017-11-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.796 16.164 -10,00
2017-11-06 2017-11-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 54.424 -0,55 145,89 -43.767 7.939.917
2017-11-06 2017-11-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.096 54.724 -1,96 144,89 -158.799 7.928.960
2017-11-06 2017-11-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 55.820 -0,71 143,54 -57.416 8.012.403
2017-11-06 2017-11-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.796 56.220 3,30 91,05 163.526 5.118.831
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 54.424 -0,37 149,34 -29.868 8.127.680
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.400 54.624 -2,50 148,40 -207.760 8.106.202
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.400 56.024 -5,72 147,75 -502.350 8.277.546
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.700 59.424 -7,33 146,52 -688.644 8.706.804
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -19.016 64.124 -22,87 145,26 -2.762.264 9.314.652
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -25.784 83.140 -23,67 144,46 -3.724.757 12.010.404
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -4.100 108.924 -3,63 143,46 -588.186 15.626.237
2017-10-31 2017-10-31 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.400 113.024 -1,22 142,38 -199.332 16.092.357
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.718 5.157 -24,99
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 114.424 -0,26 157,38 -47.214 18.008.049
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 114.724 -0,26 155,92 -46.776 17.887.766
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -818 115.024 -0,71 154,76 -126.594 17.801.114
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 115.842 -0,26 153,42 -46.026 17.772.480
2017-10-18 2017-10-16 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.718 116.142 1,50 96,87 166.423 11.250.676
2017-10-04 2017-10-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -3.437 3.438 -49,99
2017-10-04 2017-10-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 114.424 -0,52 152,62 -91.572 17.463.391
2017-10-04 2017-10-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.443 115.024 -1,24 151,82 -219.076 17.462.944
2017-10-04 2017-10-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.394 116.467 -1,18 151,04 -210.550 17.591.176
2017-10-04 2017-10-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.437 117.861 3,00 73,51 252.654 8.663.962
2017-08-04 2017-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -3.594 21.563 -14,29
2017-08-04 2017-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 114.424 -0,44 155,15 -77.575 17.752.884
2017-08-04 2017-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.494 114.924 -2,12 154,21 -384.600 17.722.430
2017-08-04 2017-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 117.418 -0,51 153,29 -91.974 17.999.005
2017-08-04 2017-08-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.594 118.018 3,14 109,14 392.249 12.880.485
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -1.796 17.960 -9,09
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -296 114.424 -0,26 156,24 -46.247 17.877.606
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 114.720 -0,35 154,89 -61.956 17.768.981
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 115.120 -0,52 153,93 -92.358 17.720.422
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 115.720 -0,43 152,50 -76.250 17.647.300
2017-08-04 2017-08-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 1.796 116.220 1,57 91,05 163.526 10.581.831
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.336 114.424 -1,15 162,04 -216.485 18.541.265
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.464 115.760 -2,91 161,38 -559.020 18.681.349
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 119.224 -0,33 159,85 -63.940 19.057.956
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.000 119.624 -0,83 158,92 -158.920 19.010.646
2017-07-21 2017-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -700 120.624 -0,58 158,08 -110.656 19.068.242
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -32.343 25.157 -56,25
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -6.303 6.875 -47,83
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -39.833 121.324 -24,72 161,00 -6.413.113 19.533.164
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 32.343 161.157 25,11 109,14 3.529.915 17.588.675
2017-07-21 2017-07-19 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 6.303 128.814 5,14 96,87 610.572 12.478.212
2017-07-19 2017-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -573 13.178 -4,17
2017-07-19 2017-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 122.511 -0,08 130,96 -13.096 16.044.041
2017-07-19 2017-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -473 122.611 -0,38 129,61 -61.306 15.891.612
2017-07-19 2017-07-17 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 573 123.084 0,47 96,87 55.507 11.923.147
2017-07-06 2017-07-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -3.438 6.875 -33,34
2017-07-06 2017-07-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.216 122.511 -0,98 128,57 -156.341 15.751.239
2017-07-06 2017-07-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.222 123.727 -1,76 127,38 -283.038 15.760.345
2017-07-06 2017-07-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.438 125.949 2,81 73,51 252.727 9.258.511
2017-06-23 2017-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -5.157 8.594 -37,50
2017-06-23 2017-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.157 122.511 -4,04 132,87 -685.211 16.278.037
2017-06-23 2017-06-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5.157 127.668 4,21 96,87 499.559 12.367.199
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -5.155 18.908 -21,42
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.155 122.511 -4,04 126,87 -654.015 15.542.971
2017-06-05 2017-06-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 5.155 127.666 4,21 96,87 499.365 12.367.005
2017-06-01 2017-05-31 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 12.500 12.500
2017-05-04 2017-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -8.979 19.756 -31,25
2017-05-04 2017-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -8.979 122.511 -6,83 121,05 -1.086.908 14.829.957
2017-05-04 2017-05-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 8.979 131.490 7,33 91,05 817.538 11.972.164
2017-04-07 2017-04-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise -8.021 10.313 -43,75
2017-04-07 2017-04-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -8.021 122.511 -6,14 114,00 -914.394 13.966.254
2017-04-07 2017-04-05 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 8.021 130.532 6,55 73,51 589.624 9.595.407
2017-04-05 2017-04-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -2.291 18.334 -11,11
2017-04-05 2017-04-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -200 122.511 -0,16 110,09 -22.018 13.487.236
2017-04-05 2017-04-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -600 122.711 -0,49 109,32 -65.592 13.414.767
2017-04-05 2017-04-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.491 123.311 -1,19 108,50 -161.774 13.379.244
2017-04-05 2017-04-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.291 124.802 1,87 73,51 168.411 9.174.195
2017-03-31 2017-03-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
M - Exercise -13.750 20.625 -40,00
2017-03-31 2017-03-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -13.750 122.511 -10,09 106,65 -1.466.438 13.065.798
2017-03-31 2017-03-29 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 13.750 136.261 11,22 73,51 1.010.762 10.016.546
2017-02-15 2017-02-13 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -5.122 122.511 -4,01 87,67 -449.046 10.740.539
2017-02-07 2017-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy)
A - Award 24.852 24.852
2017-02-07 2017-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 12.136 127.633 10,51
2017-02-07 2017-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 4.794 115.497 4,33 0,01 48 1.155
2017-02-03 2017-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.500 110.703 -1,34 85,91 -128.865 9.510.495
2017-02-03 2017-02-01 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 112.203 -0,36 85,08 -34.032 9.546.231
2016-06-10 2016-06-08 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 10.000 10.000
2016-02-04 2016-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 28.735 28.735
2016-02-04 2016-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.275 112.603 -1,12 91,80 -117.045 10.336.955
2016-02-04 2016-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.100 113.878 -0,96 90,89 -99.979 10.350.371
2016-02-04 2016-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 14.416 114.978 14,34 0,01 144 1.150
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -10.315 30.938 -25,00
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -10.315 100.562 -9,30 130,00 -1.340.950 13.073.060
2015-11-20 2015-11-18 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 10.315 110.877 10,26 73,51 758.256 8.150.568
2015-07-23 2015-07-21 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 34.000 34.000
2015-07-07 2015-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -2.291 41.253 -5,26
2015-07-07 2015-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.297 100.562 -1,27 130,63 -169.427 13.136.414
2015-07-07 2015-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 101.859 -0,10 129,54 -12.954 13.194.815
2015-07-07 2015-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -500 101.959 -0,49 128,12 -64.060 13.062.987
2015-07-07 2015-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -394 102.459 -0,38 126,69 -49.916 12.980.531
2015-07-07 2015-07-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.291 102.853 2,28 73,51 168.411 7.560.724
2015-06-11 2015-06-10 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 10.000 10.000
2015-04-06 2015-04-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -2.291 43.544 -5,00
2015-04-06 2015-04-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -545 100.562 -0,54 116,70 -63.602 11.735.585
2015-04-06 2015-04-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.746 101.107 -1,70 115,12 -201.000 11.639.438
2015-04-06 2015-04-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.291 102.853 2,28 73,51 168.411 7.560.724
2015-02-05 2015-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
A - Award 57.500 57.500
2015-02-05 2015-02-03 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 17.250 100.562 20,71 0,01 172 1.006
2015-02-04 2015-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 83.312 -0,12 110,85 -11.085 9.235.135
2015-02-04 2015-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -788 83.412 -0,94 109,80 -86.522 9.158.638
2015-02-04 2015-02-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -300 84.200 -0,36 108,64 -32.592 9.147.488
2015-01-06 2015-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -2.291 45.835 -4,76
2015-01-06 2015-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -991 84.500 -1,16 123,12 -122.012 10.403.640
2015-01-06 2015-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -1.200 85.491 -1,38 122,35 -146.820 10.459.824
2015-01-06 2015-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -100 86.691 -0,12 119,03 -11.903 10.318.830
2015-01-06 2015-01-02 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 2.291 86.791 2,71 73,51 168.411 6.380.006
2014-11-03 2014-10-30 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
A - Award 75.000 84.500 789,47 0,01 750 845
2014-10-30 2014-10-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -3.438 48.126 -6,67
2014-10-30 2014-10-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -3.438 9.500 -26,57 115,00 -395.370 1.092.500
2014-10-30 2014-10-28 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.438 12.938 36,19 73,51 252.727 951.072
2014-10-09 2014-10-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy)
M - Exercise -3.436 51.564 -6,25
2014-10-09 2014-10-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -400 9.500 -4,04 105,36 -42.144 1.000.920
2014-10-09 2014-10-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -2.134 9.900 -17,73 104,31 -222.598 1.032.669
2014-10-09 2014-10-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
S - Sale X -902 12.034 -6,97 103,64 -93.483 1.247.204
2014-10-09 2014-10-07 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
M - Exercise 3.436 12.936 36,17 73,51 252.580 950.925
2014-07-17 2014-07-15 4 VRTX VERTEX PHARMACEUTICALS INC / MA
Stock Option
A - Award 27.500 27.500
2014-07-17 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
19.000
2014-07-17 3 VRTX VERTEX PHARMACEUTICALS INC / MA
Common Stock
19.000
2014-06-17 2014-06-13 4 TTPH TETRAPHASE PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 20.000 20.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)